Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001161697-25-000026
Filing Date
2025-01-03
Accepted
2025-01-03 17:00:30
Documents
1
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 FOR 01-02-2025 form_4.html 4  
1 FORM 4 FOR 01-02-2025 form_4.xml 4 7506
  Complete submission text file 0001161697-25-000026.txt   9187
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Issuer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 24 LUCILLE LANE DIX HILLS NY 11746
Business Address
Kalb Michael Wayne (Reporting) CIK: 0001678248 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33057 | Film No.: 25507503